跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML - HSA Drug Approval Details
Approvals
/
HSA
/
PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML
Approved
THERAPEUTIC
PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML
HETERO LABS LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Mar 2, 2022
Approval ID
77b4b758b2fa52fe
Company
HETERO LABS LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
77b4b758b2fa52fe
Drug Name
PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML
Product Name
PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML
Approval Number
SIN16435P
Approval Date
2022-03-02
Registrant
HETERO SINGAPORE PTE. LTD.
Licence Holder
HETERO SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01CD01
Atc Item Name
paclitaxel
Pharma Manufacturer Name
HETERO SINGAPORE PTE. LTD.
Active Ingredients
Paclitaxel
30mg/5mL
PACLITAXEL
30 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 2, 2022
Approval ID
77b4b758b2fa52fe
Type
Therapeutic
Back to HSA Approvals
